Soleil Securities downgrades Mindray Medical (NYSE: MR) from Buy to Hold and lowers the price target from $44 to $27. The firm cites a "hazy" outlook for the future.

索雷尔证券集团(Soleil Securities Group)把迈瑞医疗公司评级从买入下调到持有，把目标股价从44美元降低到27美元，表示该公司未来前景尚不明朗。

youdao

Among the largest underlying components of GXC, in trading today Baidu, Inc. ( NASD: BIDU) is off about 0.5%, NetEase, Inc ( NASD: NTES) is down about 1.2%, and Mindray Medical International Ltd ( NYSE: MR) is lower by about 1.4%.

FORBES: SPDR S&P China ETF Experiences Big Outflow

Among the largest underlying components of GXC, in trading today NetEase, Inc ( NASD: NTES) is down about 0.1%, Mindray Medical International Ltd ( NYSE: MR) is off about 6.3%, and Sina Corp ( NASD: SINA) is lower by about 1.4%.

FORBES: GXC, NTES, MR, SINA: Large Outflows Detected at ETF

On Sunday, Securities and Exchange Commission Chairman Mary Schapiro communicated with Mr. Niederauer of the NYSE and Nasdaq CEO Robert Greifeld though phone and email, according to a person familiar with the matter.

WSJ: Behind Decision to Close Markets